-
YKL-40 may represent a novel marker for the detection of early-stage ovarian cancer. YKL-40 levels in early stage patients may also predict disease recurrence and survival. The use of YKL-40 in detection of early stage ovarian cancer deserves further investigation.
-
Routine pelvic and para-aortic lymph node dissection is not necessary in the majority of women with ovarian low malignant potential tumors.
-
-
Viagra: Maximum Capacity at High-Altitudes?; FDA Actions.
-
It is clear that the United States Cesarean section rate (CSR), while tailing off in the late 1990s, is now again rapidly heading upward. What Should be the Ideal CSR? Why the Recent Rise in CSR? Whos Most Apt to Either Offer or Comply with Patient-Requested Cesarean Section?
-
Vihtamaki and colleagues from Finland measured the circulating levels of estradiol 12 hours after the topical, percutaneous, evening administration of 1.5 mg estradiol (EstroGel) in 10 women who had been using this method of hormone therapy for at least 2 years.
-
-
GEMINI Trial; CAMELOT Trial; INVEST Trial; The Dangers of Vitamin E; FDA Actions.
-
-
Cantor and Baum, lawyers from the Yale University School of Medicine, have written an op-ed piece in the New England Journal of Medicine focusing on the central role of pharmacists in providing emergency contraception.